dual glp-1/glucagon receptor agonists Discovery of Biased Dual-Agonists of Glucagon-Like Peptide 1 and Glucagon Receptors through Mutation of a Conserved Aspartate Frontiers | GLP−1 receptor agonists

These actions improve glycemic control and support weight loss

Learn about GLP-1 Agonists: Obesity & Alzheimers Breakthrough in research and their implications for cognitive health and obesity management.

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.

Compare Farxiga (SGLT2) vs Ozempic (GLP-1): results, weight loss, A1C, safety, cost, and whether you can use them togetherplus how to choose.

Methods A retrospective study was conducted using electronic medical records from 2014 to 2019 for adults with T2D at the Valencia Clnico-Malvarrosa Department of Health (Valencia, Spain)